How does design influence patients' lives?

Published: 2020.04.30.
The healthcare industry is rapidly evolving, but so are we, when approaching new challenges. At our department we utilize the latest technologies such as virtual- and augmented reality during product development. This allows us to make our solutions tangible in the early stages of the process.
Hi my name is Isabella Kanne. I usually start my projects by gathering existing information. Thankfully in Roche we have very experienced colleagues as well as massive amounts of in-depth knowledge and expertise from previous user research activities. If we still find gaps in our internal knowledge-base, we conduct further user research to ensure we have a solid understanding of the problems our users face. Our next step in the user-centered design process is translating the insights into design concepts. The resulting concepts (often combining soft- and hardware) are tested in an early stage of the design process with users so that quick, iterative changes to our proposed designs can be made. In order to do so, we often make prototypes by ourselves; the hardware prototypes range from simple, using cardboard boxes or foam board, to more advanced, utilizing prototyping tools to produce 3D printed or milled parts. Software prototypes begin as simple wireframes on paper to interactive, high fidelity prototypes on a screen. Using these tools and methods allows us to get valuable feedback from end users on how they would interact with the proposed solution and improve the solution design accordingly, all before we even start development.


"I love translating complex challenges in the healthcare industry into intuitive solutions for healthcare professionals."
Isabella Kanne
UX Principal
slide 1 of 10 The Perspectives Programme is an excellent way of getting to know Roche and gain insights on how we are evolving personalised healthcare for the benefit of patients. It’s also a great way to focus on your strengths and the opportunities that lie ahead. Severin Schwan, CEO Roche